摘要
目的探讨急性白血病患者乳酸脱氢酶(LDH)及腺苷脱氨酶(ADA)变化的临床意义。方法收集45例急性白血病患者,动态观测其血清乳酸脱氢酶(LDH)及腺苷脱氨酶(ADA)水平。结果化疗前LDH、ADA水平较对照组和完全缓解组明显升高(P<0.05),而完全缓解组与对照组的LDH、ADA水平无显著性差异(P>0.05)。急性淋巴细胞白血病与急性髓细胞白血病的LDH、ADA水平无差异(P>0.05)。结论动态检测急性白血病患者的LDH、ADA水平有助于判断其疗效和预后。
Objective To investigate the clinical significance of changes of lactate dehydrogenase （LDH） and adenosine deaminase （ADA） in acute leukemia patients.Methods 45 cases of acute leukemia patients,the dynamic observation of serum lactate dehydrogenase （LDH） and adenosine deaminase （ADA） and horizontal. Results The LDH,ADA levels before chemotherapy,was significantly higher than the control group and the complete remission group （P0.05）,while the complete remission group and the control group,LDH,ADA was no significant difference （P0.05）. The LDH,ADA levels were unrelated between acute lymphoblastic leukemia and acute myeloid leukemia. Conclusion Dynamic Detection of acute leukemia in patients with LDH,ADA standards will help to determine its efficacy and prognosis.
出处
《当代医学》
2010年第30期113-113,77,共2页
Contemporary Medicine
